Search for Abstracts Find by Title, Author or Description Year Abstracts - 2025 - 2024 - 2023 - 2022 - 2021 - 2020 - 2019 - 2018 - 2017 - 2016 - 2015 - 2014 - 2013 - 2012 - 2011 - 2010 - 2009 Tags AB Applied Basic Science Basic Science BT Clinical Clinical-Chemotherapy-SSA-Biologics Clinical-NuclearMedicine-InterventionalRadiology-Imaging Clinical-PRRT-Nuclear Clinical-Surgical-Applied_Pathology O OT Other P Population Science Poster T Trials In Progress Search Reset Order by Title Alphabetical Title Reverse Alphabetical Most Recent First Oldest First Most popular first Last modified first [C12] Soulen (POSTER) - Randomized Embolization Trial for NeuroEndocrine Tumors (RETNET) Published in 2025 Listed under Clinical-NuclearMedicine-InterventionalRadiology-Imaging Download [C12] Soulen - Randomized Embolization Trial for NeuroEndocrine Tumors (RETNET) Published in 2025 Listed under Clinical-NuclearMedicine-InterventionalRadiology-Imaging Download [C13] Thuemmler (POSTER) - Safety and clinical implications of concurrent biopsy of neuroendocrine liver metastases at the time of liver directed therapy Published in 2025 Listed under Clinical-NuclearMedicine-InterventionalRadiology-Imaging Download [C13] Thuemmler - Safety and clinical implications of concurrent biopsy of neuroendocrine liver metastases at the time of liver directed therapy Published in 2025 Listed under Clinical-NuclearMedicine-InterventionalRadiology-Imaging Download [C14] Capdevila Castillon - Efficacy of 177Lu edotreotide vs everolimus in patients with grade 1 or grade 2 GEP NETs Phase 3 COMPETE trial (post hoc subgroup analyses) Published in 2025 Listed under Clinical-NuclearMedicine-InterventionalRadiology-Imaging Download [C15] Maluccio - Long term Follow up of PRRT Naïve Patients with GEP NETs Treated with Targeted Alpha Therapy 212Pb DOTAMTATE in the Phase 2 ALPHAMEDIX 02 Trial Published in 2025 Listed under Clinical-NuclearMedicine-InterventionalRadiology-Imaging Download [C16] Strosberg - Phase 2 Study of Targeted Alpha Therapy 212Pb DOTAMTATE in Patients with Advanced Gastroenteropancreatic (GEP) NETs Previously Treated with PRRT Published in 2025 Listed under Clinical-NuclearMedicine-InterventionalRadiology-Imaging Download [C17] Nicolas - 61Cu NODAGA LM3 versus 68Ga DOTATOC in the same patients with neuroendocrine tumors Preliminary results of the Phase I II COPPER PET in NET Trial Published in 2025 Listed under Clinical-NuclearMedicine-InterventionalRadiology-Imaging Download [C18] Tesfaye (POSTER) - Patient Characteristics and Treatment Patterns With [177Lu]Lu DOTA TATE (177Lu DOTATATE) In the US A Real World Assessment Published in 2025 Listed under Clinical-NuclearMedicine-InterventionalRadiology-Imaging Download [C18] Tesfaye - Patient Characteristics and Treatment Patterns With [177Lu]Lu DOTA TATE (177Lu DOTATATE) In the US A Real World Assessment Published in 2025 Listed under Clinical-NuclearMedicine-InterventionalRadiology-Imaging Download [C19] Halfdanarson - [212Pb]VMT alpha NET for advanced SSTR+ NETs safety and preliminary efficacy results from cohorts 1 and 2 of the dose escalation phase Published in 2025 Listed under Clinical-NuclearMedicine-InterventionalRadiology-Imaging Download [C20] Chauhan - Multi center NCI sponsored phase 1 study of triapine in combination with 177Lu dotatate in patients with progressive well differentiated gastroenteropancreatic neuroendocrine tumors (GEP NETs) Published in 2025 Listed under Clinical-NuclearMedicine-InterventionalRadiology-Imaging Download [C21] Ali (POSTER) - Single institution experience with [131I]MIBG for pheochromocytoma and paraganglioma Long term outcomes and dosimetry Published in 2025 Listed under Clinical-NuclearMedicine-InterventionalRadiology-Imaging Download [C21] Ali - Single institution experience with [131I]MIBG for pheochromocytoma and paraganglioma Long term outcomes and dosimetry Published in 2025 Listed under Clinical-NuclearMedicine-InterventionalRadiology-Imaging Download [C22] Ghanta - Systematic Literature Review and Radiomics Quality Assessment for Lung, Adrenal, Thyroid and Pituitary Neuroendocrine Tumors Published in 2025 Listed under Clinical-NuclearMedicine-InterventionalRadiology-Imaging Download [C23] Fricke - Efficacy and safety of [177Lu]Lu edotreotide ([177Lu]Lu DOTATOC) for the treatment of neuroendocrine tumors (NETs) – a systematic literature review (SLR) and meta analysis Published in 2025 Listed under Clinical-NuclearMedicine-InterventionalRadiology-Imaging Download [C24] Nicolas - First line Treatment with [177Lu]Lu edotreotide ([177Lu]Lu DOTATOC) in patients with NETs a SwissNET Registry Analysis Published in 2025 Listed under Clinical-NuclearMedicine-InterventionalRadiology-Imaging Download [C25] Fidelman (POSTER) - Safety of Transarterial Liver Directed Therapy for Metastatic Neuroendocrine Tumor for Patients with Carcinoid Heart Disease Published in 2025 Listed under Clinical-NuclearMedicine-InterventionalRadiology-Imaging Download [C25] Fidelman - Safety of Transarterial Liver Directed Therapy for Metastatic Neuroendocrine Tumor for Patients with Carcinoid Heart Disease Published in 2025 Listed under Clinical-NuclearMedicine-InterventionalRadiology-Imaging Download [C26] Koch (POSTER) - Clinical outcomes following salvage PRRT in patients with metastatic neuroendocrine tumors Published in 2025 Listed under Clinical-NuclearMedicine-InterventionalRadiology-Imaging Download [C26] Koch - Clinical outcomes following salvage PRRT in patients with metastatic neuroendocrine tumors Published in 2025 Listed under Clinical-NuclearMedicine-InterventionalRadiology-Imaging Download [C27] Chauhan (POSTER) - Efficacy and Safety of Peptide Receptor Radionuclide Therapy Retreatment (r PRRT) Practices in Progressive Neuroendocrine Tumors (prog NETs) Systematic Review and Meta Analysis Published in 2025 Listed under Clinical-NuclearMedicine-InterventionalRadiology-Imaging Download [C27] Chauhan - Efficacy and Safety of Peptide Receptor Radionuclide Therapy Retreatment (r PRRT) Practices in Progressive Neuroendocrine Tumors (prog NETs) Systematic Review and Meta Analysis Published in 2025 Listed under Clinical-NuclearMedicine-InterventionalRadiology-Imaging Download [C29] Mittra - Liver directed therapy for metastatic neuroendocrine carcinoma and grade 3 well differentiated neuroendocrine tumors Published in 2025 Listed under Clinical-NuclearMedicine-InterventionalRadiology-Imaging Download [C30] Sztangret (POSTER) - DISCO Safety, Tolerability and Diagnostic performance of 64Cu SARTATE compared to 68Ga DOTATATE in patients with known or suspected neuroendocrine tumors Published in 2025 Listed under Clinical-NuclearMedicine-InterventionalRadiology-Imaging Download [C30] Sztangret - DISCO Safety, Tolerability and Diagnostic performance of 64Cu SARTATE compared to 68Ga DOTATATE in patients with known or suspected neuroendocrine tumors Published in 2025 Listed under Clinical-NuclearMedicine-InterventionalRadiology-Imaging Download [C32] Cass - Incidence of Peripheral Inserted Central Line Complications with Administration of 177Lutetium Dotatate Published in 2025 Listed under Clinical-NuclearMedicine-InterventionalRadiology-Imaging Download [C33] Al-Toubah (POSTER) - Somatostatin receptor expression on 68Ga Dotatate imaging among patients with poorly differentiated extra pulmonary neuroendocrine carcinomas a prospective study Published in 2025 Listed under Clinical-NuclearMedicine-InterventionalRadiology-Imaging Download [C33] Al-Toubah - Somatostatin receptor expression on 68Ga Dotatate imaging among patients with poorly differentiated extra pulmonary neuroendocrine carcinomas a prospective study Published in 2025 Listed under Clinical-NuclearMedicine-InterventionalRadiology-Imaging Download [C34] Goa - Outcomes of Peptide Receptor Radionuclide Therapy in Patients with Pheochromocytoma and Paraganglioma A Center of Excellence Experience Published in 2025 Listed under Clinical-NuclearMedicine-InterventionalRadiology-Imaging Download Select the number of documents per page 5 10 15 20 25 30 50 100
